ストックスクリーナーアプリを入手
94.02
1.63%
1.2935
前日終値:
$92.73
開ける：
$94.12
24時間の取引高:
103.83K
Relative Volume:
0.31
時価総額：
$1.58B
収益：
$5.82B
当期純損益:
$-373.54M
株価収益率:
-4.1703
EPS:
-22.546
ネットキャッシュフロー:
$-87.01M
1週間 パフォーマンス:
-2.74%
1か月 パフォーマンス:
-25.07%
6か月 パフォーマンス:
+761.47%
1年 パフォーマンス:
+206.49%
1日の値動き範囲:
$92.02
$96.36
1週間の範囲:
$90.51
$100.00
52週間の値動き範囲:
$7.48
$133.04
Agilon Health Inc Stock (AGL) Company Profile
Compare AGL vs HCA, THC, FMS, EHC, DVA
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
94.08 | 1.57B | 5.82B | -373.54M | -87.01M | -22.55 |
HCA
Hca Healthcare Inc
|
429.50 | 88.13B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
277.50 | 21.62B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.40 | 12.69B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
120.75 | 12.01B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
175.33 | 11.31B | 13.84B | 1.10B | 1.49B | 10.42 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-20 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2025-08-06 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-04-25 | アップグレード | Citigroup | Neutral → Buy |
| 2025-04-08 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2025-01-10 | アップグレード | Citigroup | Sell → Neutral |
| 2025-01-10 | 開始されました | Needham | Hold |
| 2024-12-16 | 開始されました | Macquarie | Neutral |
| 2024-12-11 | 開始されました | Bernstein | Mkt Perform |
| 2024-11-11 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-11-08 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-10-30 | ダウングレード | Citigroup | Neutral → Sell |
| 2024-10-02 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-05-30 | 開始されました | Robert W. Baird | Neutral |
| 2024-04-22 | 開始されました | Citigroup | Neutral |
| 2024-03-06 | 開始されました | Barclays | Underweight |
| 2024-02-26 | ダウングレード | Jefferies | Buy → Hold |
| 2024-02-26 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2024-01-08 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-01-08 | ダウングレード | Stifel | Buy → Hold |
| 2024-01-08 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-01-05 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-01-05 | ダウングレード | Truist | Buy → Hold |
| 2023-12-11 | ダウングレード | Goldman | Buy → Neutral |
| 2023-12-06 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-11-21 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2023-10-20 | 開始されました | The Benchmark Company | Buy |
| 2023-06-13 | 開始されました | Evercore ISI | In-line |
| 2022-12-09 | 開始されました | Stifel | Buy |
| 2022-09-14 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-09-12 | 開始されました | Goldman | Buy |
| 2022-09-07 | 再開されました | Truist | Buy |
| 2022-06-24 | 開始されました | BTIG Research | Neutral |
| 2022-03-30 | 開始されました | Guggenheim | Buy |
| 2021-10-20 | 開始されました | Jefferies | Buy |
| 2021-09-27 | 開始されました | SVB Leerink | Outperform |
| 2021-09-10 | 開始されました | Cowen | Outperform |
| 2021-05-11 | 開始されました | William Blair | Outperform |
| 2021-05-10 | 開始されました | BofA Securities | Buy |
| 2021-05-10 | 開始されました | Deutsche Bank | Buy |
| 2021-05-10 | 開始されました | Goldman | Buy |
| 2021-05-10 | 開始されました | JP Morgan | Overweight |
| 2021-05-10 | 開始されました | Truist | Buy |
| 2021-05-10 | 開始されました | Wells Fargo | Overweight |
| 2021-05-10 | 開始されました | Wolfe Research | Outperform |
すべてを表示
Agilon Health Inc (AGL) 最新ニュース
agilon health to Participate in Upcoming Conferences - Yahoo Finance
Agilon Health (NYSE:AGL) Trading Up 5.4%Here's Why - MarketBeat
Q2 Earnings Highlights: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks - Yahoo Finance
AQR Capital Management Trims Agilon Health (AGL) Stake Amid Stoc - GuruFocus
agilon health (AGL) insider’s 17-share move is just tax withholding - Stock Titan
Agilon Health (AGL) Q2 2026 Earnings Call Transcript - AOL.com
Agilon Health (AGL) Institutional Ownership 2026 $AGL - MarketBeat
Agilon Health, Inc. (NYSE:AGL) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Bernstein Reaffirms Their Hold Rating on Agilon Health (AGL) - The Globe and Mail
Agilon Health Inc (AGL) Stock Up 9.0% but GF Value Says Overvalued -- GF Score: 71/100 - GuruFocus
Agilon Health (NYSE:AGL) Trading 8.5% HigherHere's What Happened - MarketBeat
Should agilon health’s (AGL) Profit Rebound and Higher Guidance Prompt a Fresh Look From Investors? - simplywall.st
AGL|agilon health inc|Price:89.299|Chg%:+3.039 - TradingKey
5 Insightful Analyst Questions From agilon health’s Q2 Earnings Call - Yahoo Finance
Agilon Health (NYSE:AGL) Valuation Debate Grows After Guidance - Kalkine Media
Why Is AGL Stock Rising Today? - Stocktwits
Has Agilon Health (AGL) Outpaced Other Medical Stocks This Year? - Yahoo Finance
AQR Capital discloses 4.15% agilon health (AGL) stake in Schedule 13G/A - Stock Titan
Is Agilon Health Inc (AGL) a Bargain After 10.7% Drop? GF Value Says Undervalued - GuruFocus
Goldman Sachs Group (AGL) discloses 3.9% beneficial stake in agilon health - Stock Titan
Citigroup Upgrades Agilon Health to Neutral From Sell, Adjusts Price Target to $115 From $105 - marketscreener.com
Citi Maintains Agilon Health(AGL.US) With Hold Rating, Maintains Target Price $115 - Moomoo
AGILON HEALTH, INC. : CITIGROUP RAISES TO NEUTRAL FROM SELL; RAISES TARGET PRICE TO $115 FROM $105 - Bitget
Agilon Health (AGL) Short Interest & Short Float | Updated Aug 2026 $AGL - marketbeat.com
Citi Upgrades Agilon Health(AGL.US) to Hold Rating, Raises Target Price to $115 - Moomoo
Weekly Recap: Cash, debt & guidance and CHF rollout, clinical expansion - TradingView
Agilon Health Earnings Call Signals Profitable Turnaround - The Globe and Mail
TD Cowen Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $95 - Moomoo
Can agilon health (AGL) Justify Its Valuation As Earnings Turned Profitable? - Yahoo Finance
agilon health: The Q2 Inflection Is Real (NYSE:AGL) - Seeking Alpha
Analysts Offer Insights on Healthcare Companies: Agilon Health (AGL), Qiagen (QGEN) and Coherus Biosciences (CHRS) - The Globe and Mail
A Quick Look at Today's Ratings for Agilon Health(AGL.US), With a Forecast Between $105 to $140 - Moomoo
Baird Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $116 - Moomoo
Evercore Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $125 - Moomoo
agilon health, inc. Stock 12‑Month Price Target Raised to $106.69, Implies 1% Downside - TradingView
Agilon Health (NYSE:AGL) Trading Down 9.9%What's Next? - MarketBeat
agilon health (AGL) Is Up 16.4% After Q2 Return To Profitability And Raised 2026 Outlook - simplywall.st
A Quick Look at Today's Ratings for Agilon Health(AGL.US), With a Forecast Between $105 to $125 - Moomoo
Agilon Health Q2 Earnings Call Highlights - TradingView
AGILON HEALTH, INC. : BENCHMARK RAISES TARGET PRICE TO $140 FROM $95 - Moomoo
Earnings call transcript: Agilon Health tops Q2 2026 estimates and lifts outlook - Investing.com
Agilon Health (AGL) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
agilon health, inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Agilon Health (NYSE:AGL) Releases Earnings Results, Beats Estimates By $0.92 EPS - MarketBeat
Agilon: Q2 Earnings Snapshot - Barchart.com
Agilon Health tops Q2 estimates, raises 2026 guidance; Shares gain 3% - Investing.com South Africa
AGL Stock Jumps As Wells Fargo Doubles Price Target - StocksToTrade
(AGL) agilon health, inc. Expects Q3 Revenue Range $1.45B$1.48B - marketscreener.com
agilon health, inc. 2026: Revenue $1.49B, EPS $1.04— 10-Q Summary - TradingView
Earnings Flash (AGL) agilon health, inc. Reports Q2 Revenue $1.5B, vs. FactSet Est of $1.45B - marketscreener.com
Agilon Health Inc (AGL) 財務データ
収益
当期純利益
現金流量
EPS
0.99%
1.74%
大文字化:
|
ボリューム (24 時間):